In a revolutionary medical procedure, insulin-producing cells derived from a young woman’s own body were successfully ...

Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced the appointment of Sumeet Ambarkhane, M.D., as Chief ...

Tuberculosis (TB) is a serious bacterial infection that primarily affects the lungs but can spread to other organs. We got in ...

This year’s theme is “Yes! We Can End TB: Commit, Invest, Deliver”. It offers an opportunity to reflect on ongoing efforts ...

Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...

The first case of breast TB was recorded by Sir Astley Cooper who described it as "scrofulous swelling of the bosom". Now it ...

India aims to eradicate tuberculosis by 2025, focusing on prevention, early detection, and treatment for success.

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

The BPaLM regimen promises a breakthrough in MDR-TB treatment with a shorter, all-oral approach. However, high costs, limited ...

Astragalus is a powerful adaptogen with immune-boosting, anti-inflammatory, and anti-ageing benefits. Backed by both ...

The global IgA nephropathy disease treatment market is poised for substantial growth, with projections indicating a robust CAGR of 20.8% during the forecast period from 2022 to 2028. This growth is ...